Hero image for "The FY27 Defense Bill Just Told You Exactly Where to Look"

The FY27 Defense Bill Just Told You Exactly Where to Look


The House Appropriations Committee dropped the FY27 Defense Appropriations bill today, and buried inside the $1.072 trillion total is a line that should get defense tech investors' attention: over $7.5 billion for hypersonic weapons and test infrastructure.

That number lands at an interesting moment. DIU just expanded its Hermeus contract to $219 million — the additional $159 million funding Quarterhorse flight tests through 2027, specifically to gather high-speed payload release data. I covered the original DIU bet when it was announced. What's changed is the budget context around it.

The FY27 bill isn't just funding weapons — it's funding the testing infrastructure to validate them. That's the part that usually gets cut or delayed, and it's the part that actually determines whether a startup's flight data ever becomes a program of record. When Congress explicitly appropriates for test infrastructure alongside the weapons themselves, it removes one of the most reliable ways promising programs die quietly.

The bill also explicitly prioritizes DIU, APFIT, and the Civil Reserve Manufacturing Network — the procurement pathways that startups actually use. That's not accidental language. It reflects a theory of acquisition: get capability to warfighters faster by routing around traditional procurement timelines.

The pattern here is worth tracking. Hermeus is building toward Mach 3 on Quarterhorse before transitioning to its hypersonic Darkhorse follow-on. The FY27 bill creates the budget environment where that roadmap has a customer waiting at the end of it. Meanwhile, Apex's $2.3 billion valuation signals that investors are pricing in exactly this kind of sustained government demand for high-speed, high-altitude capability.

The subcommittee markup is scheduled for June 11th. Watch what survives the closed session — specifically whether the test infrastructure line holds. That's the tell.